-+ 0.00%
-+ 0.00%
-+ 0.00%

DOGWOOD THERAPEUTICS INC - SERPIN PHARMA AWARDED $2.5 MLN GRANT FROM NATIONAL CANCER INSTITUTE FOR SP16 PHASE 1B TRIAL

Reuters·04/15/2026 13:00:00

Please log in to view news